following the manufacturer's instructions. CMV-galactosidase plasmid (150 ng per well) was used as an internal control to normalize transfection efficiency.
Quantification of Calcium Deposition
For measuring calcium deposited in the extracellular matrix of the cells, the cells were washed with PBS and then decalcified with 0.6N HCl overnight and calcium contents in the supernatant were determined colorimetrically by the o-cresolphthaleincomplexone method (Bioassay System, Lee et. al., PDK4 Exacerbates Vascular Calcification 12 Cat.DICA500). The remaining cells were washed with PBS and solubilized with lysis buffer (0.1N NaOH and 0.1% SDS) and total protein contents were determined by the bicinchoninic acid (BCA) method (Pierce). Total calcium content was normalized by total protein content for each culture. For calcium quantification in aortic tissues, aortic segments were weighed and decalcified with 0.6N HCl for 24 h, and then calcium content was determined according to the above procedure and the data were expressed as calcium per mg of dry aortic tissues
Adenovirus-mediated overexpression of PDK4 in VSMCs
Recombinant adenovirus expressing PDK4 was provided by Dr. Young-Bum Kim (Harvard Medical School, MA). The recombinant adenovirus was amplified in HEK-293 cells and purified using CsCl (Sigma) gradient centrifugation. The preparation were collected and desalted, and the titers were determined using Adeno-X Rapid titer according to the manufacturer's instructions (BD Bioscience).
VSMCs were infected with adenoviruses expressing PDK4 or GFP protein (control) at various multiplicities of infection (MOI) for 3 h and incubated with growth medium supplemented with or without various concentrations of Pi and DCA. The infection efficiency was determined by fluorescence intensity of GFP.
Binding model prediction of PDK4 and SMAD5
The structure of PDK4 in complex with ADP was obtained from the Protein Data Bank (http://www.pdb.org, pdb code: 2E0A). Discovery Studio3.5 (http://www.accelrys.com) with MODELLER was used for the homology model building of SMAD5. The template structure of SMAD1 (pdb code: 1KHU) was used to build the homology model. The initial PDK4 and SMAD5 structures were minimized by the steepest descent method for 5,000 iterations using the CHARMm force field (Accelrys, San Diego, CA, USA). To predict PDK4-SMAD5 binding model, the ZDOCK and RDOCK programs in Discovery Studio 3.5 (Accelrys) were used. ZDOCK for PDK4-SMAD5 docking included using a filter feature to specify the residues involved in the binding interface since the autophosphorylation site of PDK4 and the SMAD5 phosphorylation site are expected to be involved. The top 2,000 predictions for each case were generated using ZDOCK at a 6° rotational sampling density with each of the scoring functions. Clusters of similar docking pose and the topscoring cluster were selected for the PDK4-SMAD5 complex. The molecular graphics for the binding-model structure were generated using the PyMol package (http://www.pymol.org).
Micro-CT analysis
To determine the three-dimensional bone structure in vivo, histomorphometric analyses were performed using a Micro-CT system (eXplore Locus SP scanner GE Healthcare) at 8 µm resolution.
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The morphometric parameters were determined using eXplore MicroView program (GE Healthcare; version 2.2). For the femur analysis, the scanned regions were confined to the distal metaphysis, extending proximally 1.7 mm from the proximal tip of the primary spongiosa.
Immunohistochemistry
The vessels were routinely processed for paraffin embedding at a thickness of 10 μm after 4%
paraformaldehyde fixation for the analysis. The sections were de-paraffinized and antigens were retrieved using an IHC-Tek Epitope Retrieval Steamer Set (IHC World (IW-1102), Woodstock, MD, USA) in 0.01 M citrate buffer (pH 6.0) at 95°C for 40 min, followed by overnight incubation with antibodies against p-PDHE1 S293 and S300 (Calbiochem, Cat # AP1062, AP1064, AP1063, respectively) at 4°C and detection using secondary antibodies with HRP, using the UltraVision LP Detection System (Thermo Scientific, Waltham, MA, USA). Nuclei were counterstained with
Mayer's hematoxylin (Lillie's modification).
